Evidence map›Paper›PMID 24023874›Full record

ArticlePloS one2013

Functional cross talk between CXCR4 and PDGFR on glioblastoma cells is essential for migration.

Miriam Sciaccaluga, Giuseppina D'Alessandro, Francesca Pagani, Giuseppina Ferrara, Nadia Lopez, Tracy Warr, Paolo Gorello, Alessandra Porzia, Fabrizio Mainiero, Antonio Santoro and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme.International journal of molecular sciences · 2021
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Miriam SciaccalugaIRCCS Neuromed, Venafro, Italy.
Giuseppina D'Alessandro
Francesca Pagani
Giuseppina Ferrara
Nadia Lopez
Tracy Warr
Paolo Gorello
Alessandra Porzia
Fabrizio Mainiero
Antonio Santoro
Vincenzo Esposito
Giampaolo Cantore
Emilia Castigli
Cristina Limatola
University of Perugia · ITIstituto Neurologico Mediterraneo · ITSapienza University of Rome · ITItalian Institute of Technology · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma (GBM) is the most common and aggressive form of brain tumor, characterized by high migratory behavior and infiltration in brain parenchyma which render classic therapeutic approach ineffective. The migratory behaviour of GBM cells could be conditioned by a number of tissue- and glioma-derived cytokines and growth factors. Although the pro-migratory action of CXCL12 on GBM cells in vitro and in vivo is recognized, the molecular mechanisms involved are not clearly identified. In fact the signaling pathways involved in the pro-migratory action of CXCL12 may differ in individual glioblastoma and integrate with those resulting from abnormal expression and activation of growth factor receptors. In this study we investigated whether some of the receptor tyrosine kinases commonly expressed in GBM cells could cooperate with CXCL12/CXCR4 in their migratory behavior. Our results show a functional cross-talk between CXCR4 and PDGFR which appears to be essential for GBM chemotaxis.

Indexed as

ChemotaxisReceptor Cross-TalkCell Line, TumorGene Expression Regulation, NeoplasticGlioblastomaHumansReceptor, Platelet-Derived Growth Factor betaReceptors, CXCR4Tyrphostins6,7-dimethoxy-3-phenylquinoxalineCXCR4 protein, humanReceptor, Platelet-Derived Growth Factor betaReceptors, CXCR4Tyrphostins

Identifiers

PMID24023874
PMCPMC3759384
OpenAlexW2059927827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.